nemolizumab (Mitchga)

From Aaushi
Jump to navigation Jump to search

Indications

Adverse effects

  • serious treatment-emergent adverse events in < 3%

Mechanism of action

More general terms

References

  1. Silverberg JI, Wollenberg A, Reich A, et al. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials. Lancet. 2024 Jul 24:S0140-6736(24)01203-0 PMID: https://www.ncbi.nlm.nih.gov/pubmed/39067461